FDA Clears Zebra Medical AI Solution For Identifying Compression Fractures News Briefs

Zebra Medical Vision, the deep-learning medical imaging analytics company, announced on Monday that it secured its 5th FDA clearance, this time for an AI solution that identifies findings suggestive of compression fractures in scans. The Israeli firm said the FDA gave 510(k) clearance for its Vertebral Compression Fractures (VCF) product that enables clinicians to place patients at risk of osteoporosis "in treatment pathways to prevent potentially life-changing fractures," Zebra Medical said in a statement. The solution can be applied to abdominal or chest CT scan performed for any clinical indication, the company says. Founded in 2014 by Eyal Toledano, Eyal Gura, and Elad Benjamin, Zebra uses AI to read medical scans and automatically detect anomalies. Through its development and use of different algorithms, Zebra Medical has been able to identify visual symptoms for diseases such as breast cancer, osteoporosis, and fatty liver, as well as conditions such as aneurysms and brain bleeds.